Provention bio to report second quarter 2021 financial results on august 5, 2021

Red bank, n.j., july 29, 2021 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it will report its second quarter 2021 financial results on thursday, august 5, 2021, before the opening of the u.s. financial markets.
PRVB Ratings Summary
PRVB Quant Ranking